AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Bank of America Securities Reiterates Buy Rating for Novo Nordisk with DKK550 Price Target
ByAinvest
Monday, Jul 7, 2025 8:56 am ET1min read
Bank of America Securities analyst Sachin Jain maintained a Buy rating and DKK550 price target for Novo Nordisk. The analyst consensus is a Moderate Buy with an average price target of DKK629.17, representing a 41.48% upside. Novo Nordisk's market cap is DKK1943.9B and has a P/E ratio of 18.61. Corporate insider sentiment is negative, with 31 insiders selling their shares in the past quarter.
July 02, 2025Bank of America Securities analyst Sachin Jain maintained a Buy rating for Novo Nordisk (NVO) on July 1, with a price target of DKK550.00. The company's shares closed at DKK444.71 on the previous day. This rating aligns with the broader analyst consensus, which is a Moderate Buy, with an average price target of DKK629.17, representing a 41.48% upside [3].
Novo Nordisk, a Danish pharmaceutical company with a market cap of DKK1943.9 billion, operates in two primary business segments: Diabetes and Obesity Care, and Rare Disease. The company reported a consolidated turnover of approximately $44 billion on a TTM basis [4]. The company's current P/E ratio is 18.61, indicating its valuation relative to earnings [3].
The analyst consensus on Novo Nordisk is a Moderate Buy, with a price target of DKK629.17, indicating a significant upside potential. UBS also maintained a Buy rating on the stock with a DKK700.00 price target [3]. Despite the positive analyst ratings, corporate insider sentiment has been negative, with 31 insiders selling their shares in the past quarter [3].
Novo Nordisk has been in the news recently for its plans to upgrade its factory in Anagni, Italy, with a planned investment of €2 billion ($2.34 billion). The Italian government has designated the project as being of "pre-eminent strategic interest," allowing for fast-tracking of approval procedures [2].
References:
[1] https://www.marketscreener.com/quote/stock/NOVO-NORDISK-A-S-1412980/consensus/
[2] https://www.investing.com/news/stock-market-news/italy-appoints-commissioner-to-accelerate-novo-nordisk-factory-investment-93CH-4124747
[3] https://www.theglobeandmail.com/investing/markets/stocks/NVO/pressreleases/33238912/bank-of-america-securities-sticks-to-its-buy-rating-for-novo-nordisk-0qiu/
[4] https://seekingalpha.com/article/4799487-novo-nordisks-sell-off-has-gone-too-far?source=affiliate_program:stockanalysis.com&utm_medium=affiliate&utm_source=stockanalysis.com&affid=858&oid=16&transaction=2c281206c3a94273909240dabb97b22f
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet